{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:29:14Z","timestamp":1784132954506,"version":"3.55.0"},"reference-count":0,"publisher":"BMJ","issue":"5652","license":[{"start":{"date-parts":[[1969,5,3]],"date-time":"1969-05-03T00:00:00Z","timestamp":-20995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J"],"published-print":{"date-parts":[[1969,5,3]]},"abstract":"<jats:p>\n                    Differences in the metabolic fate of antithyroid drugs influence the optimal frequency of administration and their therapeutic efficacy.\n                    <jats:sup>35<\/jats:sup>\n                    S propylthiouracil differed from the\n                    <jats:sup>35<\/jats:sup>\n                    S imidazoles (carbimazole and methimazole) in the more rapid absorption and excretion and the shorter biological half-life in the plasma of the former. Renal function may have a more important influence on the biological half-life of the drugs than thyroid status. Further work is required to determine the optimal frequency of administration for each compound.\n                  <\/jats:p>","DOI":"10.1136\/bmj.2.5652.290","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T07:02:10Z","timestamp":1238655730000},"page":"290-291","source":"Crossref","is-referenced-by-count":43,"title":["Metabolism of 35S-labelled Antithyroid Drugs in Man"],"prefix":"10.1136","volume":"2","author":[{"given":"W. D.","family":"Alexander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"MacAulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. F.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Londono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1969,5,3]]},"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.2.5652.290","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.2.5652.290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T16:43:21Z","timestamp":1764953001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.2.5652.290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1969,5,3]]},"references-count":0,"journal-issue":{"issue":"5652","published-online":{"date-parts":[[1969,5,3]]},"published-print":{"date-parts":[[1969,5,3]]}},"alternative-id":["10.1136\/bmj.2.5652.290"],"URL":"https:\/\/doi.org\/10.1136\/bmj.2.5652.290","relation":{},"ISSN":["0007-1447","1468-5833"],"issn-type":[{"value":"0007-1447","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1969,5,3]]}}}